BR55 in Characterization of Ovarian Lesions

Summary

This is an exploratory phase II, single center, open label, prospective study of BR55 CEUS for characterization of ovarian lesions in subjects with suspected ovarian cancer.

Timeline

Start

2018-12-13

Primary completion

2021-04-15

Completion

2021-07-31

Outcome

Outcome not reported

Stopped (Enrollment): “Sponsor decision; expiration of available study agent due to long recruitment timeline.”

Drugs

Indications